Quick Answer
Apyx Medical Corp reported Research And Development Expense of $3.37 million for the year ending 2025.
- Apyx Medical Corp showed a decrease of -33.6% in Research And Development Expense from 2024 to 2025.
- This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $347.0 thousand | Q2 2011: $289.0 thousand | Q3 2011: $288.0 thousand | Q1 2012: $298.0 thousand | Q2 2012: $349.0 thousand | Q3 2012: $322.0 thousand | Q1 2013: $333.0 thousand | Q2 2013: $314.0 thousand | Q3 2013: $291.0 thousand | Q1 2014: $332.0 thousand | Q2 2014: $318.0 thousand | Q3 2014: $368.0 thousand | Q1 2015: $446.0 thousand | Q2 2015: $505.0 thousand | Q3 2015: $583.0 thousand | Q1 2016: $668.0 thousand | Q2 2016: $592.0 thousand | Q3 2016: $681.0 thousand | Q1 2017: $709.0 thousand | Q2 2017: $696.0 thousand | Q3 2017: $487.0 thousand | Q1 2018: $514.0 thousand | Q2 2018: $763.0 thousand | Q3 2018: $613.0 thousand | Q1 2019: $730.0 thousand | Q2 2019: $888.0 thousand | Q3 2019: $1.02 million | Q1 2020: $980.0 thousand | Q2 2020: $975.0 thousand | Q3 2020: $1.05 million | Q1 2021: $1.12 million | Q2 2021: $1.08 million | Q3 2021: $1.18 million | Q1 2022: $1.16 million | Q2 2022: $1.07 million | Q3 2022: $1.06 million | Q1 2023: $1.27 million | Q2 2023: $1.36 million | Q3 2023: $1.41 million | Q1 2024: $1.40 million | Q2 2024: $1.42 million | Q3 2024: $1.14 million | Q1 2025: $804.0 thousand | Q2 2025: $824.0 thousand | Q3 2025: $801.0 thousand.
- Over the full 17 years of available data (2009 to 2025), Apyx Medical Corp's Research And Development Expense has grown by 61.9%.
- Historical annual values: Fiscal year 2025: $3.37 million | Fiscal year 2024: $5.08 million | Fiscal year 2023: $5.44 million | Fiscal year 2022: $4.54 million | Fiscal year 2021: $4.32 million | Fiscal year 2020: $3.92 million | Fiscal year 2019: $3.73 million | Fiscal year 2018: $2.55 million | Fiscal year 2017: $1.94 million | Fiscal year 2016: $1.03 million | Fiscal year 2015: $2.16 million | Fiscal year 2014: $1.42 million | Fiscal year 2013: $1.26 million | Fiscal year 2012: $1.33 million | Fiscal year 2011: $1.20 million | Fiscal year 2010: $1.85 million | Fiscal year 2009: $2.08 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: